GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

China Renaissance Holdings 1911.HK · HKD

Financials · HKEX · 🇭🇰 Hong Kong

Compare

4.00

+8.99%

Close of 9 Nov 2026, in HKD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CNY, from our data supplier.

FY2025

Revenue, before interest expense

CN¥1.34bn

FY2016FY2025

Net income

CN¥115.0m

FY2016FY2025

Total assets

CN¥11.22bn

FY2016FY2025

Shareholders' equity

CN¥7.12bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue, before interest expenseCN¥1.34bnCN¥823.6mCN¥848.3mCN¥1.56bnCN¥2.03bnCN¥1.59bnCN¥1.30bnCN¥1.45bnCN¥910.2mCN¥926.0m
Research and development—CN¥39.9m—CN¥41.8mCN¥89.3mCN¥57.6mCN¥90.5mCN¥84.4mCN¥65.1mCN¥41.0m
Operating incomeCN¥601.6m−CN¥41.6m−CN¥178.3m−CN¥270.6mCN¥1.00bnCN¥1.19bnCN¥251.5mCN¥162.9m−CN¥30.0mCN¥302.5m
Net incomeCN¥115.0m−CN¥179.0m−CN¥471.9m−CN¥429.9mCN¥1.89bnCN¥1.04bnCN¥246.8m−CN¥1.91bnCN¥208,918CN¥221.0m
Diluted earnings per share0.20-0.35-0.93-0.853.441.950.46-4.430.000.40

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsCN¥11.22bnCN¥10.56bnCN¥9.34bnCN¥15.23bnCN¥16.49bnCN¥12.54bnCN¥9.51bnCN¥7.32bnCN¥4.84bnCN¥2.56bn
Cash and short-term investmentsCN¥5.20bnCN¥4.37bnCN¥4.11bnCN¥6.53bnCN¥6.58bnCN¥4.79bnCN¥5.57bnCN¥4.80bnCN¥3.67bnCN¥1.78bn
Total liabilitiesCN¥2.94bnCN¥3.51bnCN¥2.16bnCN¥6.45bnCN¥7.29bnCN¥5.16bnCN¥2.84bnCN¥922.0mCN¥3.28bnCN¥2.03bn
DebtCN¥495.3mCN¥636.5mCN¥629.4mCN¥2.62bnCN¥3.29bnCN¥1.24bnCN¥239.8m—CN¥2.94bnCN¥1.61bn
Shareholders' equityCN¥7.12bnCN¥6.04bnCN¥6.14bnCN¥7.57bnCN¥7.95bnCN¥5.90bnCN¥5.16bnCN¥4.94bnCN¥99.8mCN¥19.8m
Shares outstanding573m517m506m507m550m533m541m432m548m548m

Financial ratios

Data as of 28 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Operating margin14.1%-7.0%-34.2%-17.3%84.1%67.7%——
Net margin8.6%-17.7%-55.6%-27.5%69.0%59.2%——
Return on equity1.6%-3.0%-7.7%-6.6%23.8%17.6%——
Return on assets1.0%-1.7%-5.1%-3.3%11.5%8.3%——
Revenue growth14.0%19.1%-45.7%-33.7%34.2%34.5%——
Earnings growth-155.2%-62.1%9.8%-126.5%56.5%320.5%——
Current ratio12.91x2.03x2.95x2.31x1.73x1.70x——
Debt to equity0.07x0.11x0.10x0.37x0.47x0.25x——
Equity ratio63.4%57.2%65.7%49.7%48.2%47.0%——
Interest coverage32.02x-0.76x-5.74x-0.73x15.94x44.19x——
R&D as a share of sales—3.9%—2.7%3.3%3.3%6.9%6.1%
Buybacks as a share of market value-10.9%-2.1%0.2%7.5%-4.1%2.7%——

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-4.9%-3.3%4.0%
Operating income—-12.7%3.1%
Net income—-35.6%-6.2%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin25.9%2.4%28.1%25.1%
Net margin-3.0%-21.1%24.0%5.4%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Price to earnings17.8-7.3-2.3-2.81.32.49.7-1.3
Price to sales1.51.61.30.81.21.61.81.7

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years. Last went ex-dividend on 5 Jul 2022.

FY2022FY2021FY2020
Paid in the year0.4450.4560.164

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.